This company has shut down. Intergalactic Therapeutics is no longer operating — its last tracked round was a Series A in 2021.
Explore the Startup GraveyardIntergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
Intergalactic Therapeutics has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.
Intergalactic Therapeutics's investors include Apple Tree Partners.
Intergalactic Therapeutics is headquartered in Boston, United States.
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
Intergalactic Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Intergalactic Therapeutics — Funding & Investors." VCBacked, October 7, 2021, https://www.vcbacked.co/company/intergalactic-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Intergalactic Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/intergalactic-therapeutics
{{cite web |title=Intergalactic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/intergalactic-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated